Integration of denosumab therapy in the management of giant cell tumors of bone

被引：7
|
作者：
Miles, Daniel T. [1 ]
Voskuil, Ryan T. [2 ,3 ]
Dale, Wood [4 ]
Mayerson, Joel L. [2 ,3 ]
Scharschmidt, Thomas J. [2 ,3 ]
机构：
[1] Univ Tennessee, Coll Med, Dept Orthopaed Surg, Chattanooga, TN USA
[2] Ohio State Univ, James Canc Hosp, Div Musculoskeletal Oncol, Wexner Med Ctr,Nationwide Childrens Hosp, Columbus, OH 43210 USA
[3] Ohio State Univ, Solove Res Inst, Wexner Med Ctr, Nationwide Childrens Hosp, Columbus, OH 43210 USA
[4] Univ Mississippi, Sch Med, Dept Orthopaed & Rehabil, University, MS 38677 USA
来源：
JOURNAL OF ORTHOPAEDICS | 2020年 / 22卷
关键词：
Denosumab; RANKL; Giant cell tumor of the bone (GCTB); PHASE-II TRIAL; LOCAL RECURRENCE; ZOLEDRONIC ACID; BREAST-CANCER; OPEN-LABEL; PROSTATE-CANCER; GENE-EXPRESSION; CATHEPSIN-K; RANK LIGAND; OSTEOPROTEGERIN;
D O I：
10.1016/j.jor.2020.03.020
中图分类号：
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学（修复外科学）];
学科分类号：
摘要：
A review of the literature indicated denosumab is gaining favorability in the oncology community, particularly with increasing frequency in GCTB. Will denosumab be the breakthrough GCTB treatment? Here, we provide a pertinent case example, a review of the literature regarding the history and basic science behind the use of denosumab for GCTB, highlight the newest insights into the dosing and duration of treatment, and note advancements in the field.
引用
收藏
页码：38 / 47
页数：10
相关论文
共 50 条
  • [1] Integration of denosumab therapy in the management of giant cell tumors of bone (vol 22, pg 38, 2020)
    Miles, Daniel T.
    Voskuil, Ryan T.
    Dale, Wood
    Mayerson, Joel L.
    Scharschmidt, Thomas J.
    JOURNAL OF ORTHOPAEDICS, 2021, 23 : 275 - 275
  • [2] Denosumab for the management of giant cell tumours of bone
    Papanikola, G.
    Aubry-Rozier, B.
    SWISS MEDICAL WEEKLY, 2017, 147 : 5S - 5S
  • [3] The Evaluation and Management of Lung Metastases in Patients with Giant Cell Tumors of Bone in the Denosumab Era
    Trovarelli, Giulia
    Rizzo, Arianna
    Cerchiaro, Mariachiara
    Pala, Elisa
    Angelini, Andrea
    Ruggieri, Pietro
    CURRENT ONCOLOGY, 2024, 31 (04) : 2158 - 2171
  • [4] Denosumab for the Giant Cell Tumors
    Hardes, J.
    ORTHOPADE, 2018, 47 (05): : 443 - 443
  • [5] Challenges of denosumab in giant cell tumor of bone, and other giant cell-rich tumors of bone
    Lipplaa, Astrid
    Dijkstra, Sander
    Gelderblom, Hans
    CURRENT OPINION IN ONCOLOGY, 2019, 31 (04) : 329 - 335
  • [6] Diagnosis and monitoring denosumab therapy of giant cell tumors of bone: radiologic-pathologic correlation
    Maryse Lejoly
    Thomas Van Den Berghe
    David Creytens
    Wouter Huysse
    Lore Lapeire
    Gwen Sys
    Koenraad Verstraete
    Skeletal Radiology, 2024, 53 : 353 - 364
  • [7] Diagnosis and monitoring denosumab therapy of giant cell tumors of bone: radiologic-pathologic correlation
    Lejoly, Maryse
    van den Berghe, Thomas
    Creytens, David
    Huysse, Wouter
    Lapeire, Lore
    Sys, Gwen
    Verstraete, Koenraad
    SKELETAL RADIOLOGY, 2024, 53 (02) : 353 - 364
  • [8] DENOSUMAB: AN ALTERNATIVE THERAPY FOR THE MANAGEMENT OF GIANT CELL LESIONS
    O'Connell, John Edward
    Kearns, Gerard J.
    JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2016, 74 (05) : 873 - 873
  • [9] Protein Expression Profiling of Giant Cell Tumors of Bone Treated with Denosumab
    Mukaihara, Kenta
    Suehara, Yoshiyuki
    Kohsaka, Shinji
    Akaike, Keisuke
    Tanabe, Yu
    Kubota, Daisuke
    Ishii, Midori
    Fujimura, Tsutomu
    Kazuno, Saiko
    Okubo, Taketo
    Takagi, Tatsuya
    Yao, Takashi
    Kaneko, Kazuo
    Saito, Tsuyoshi
    PLOS ONE, 2016, 11 (02):
  • [10] Management of Central Giant Cell Granuloma With Subcutaneous Denosumab Therapy
    Naidu, Aparna
    Malmquist, Michael P.
    Denham, Claude A.
    Schow, Sterling R.
    JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2014, 72 (12) : 2469 - 2484
12345